K
Kwang Hyub Han
Researcher at Yonsei University
Publications - 694
Citations - 36674
Kwang Hyub Han is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis B virus. The author has an hindex of 80, co-authored 692 publications receiving 30974 citations. Previous affiliations of Kwang Hyub Han include University Health System.
Papers
More filters
Journal ArticleDOI
6 Phase II, multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV
C.L. Lai,Kwang Hyub Han,S.K. Yoon,S.H. Um,M.F. Yuen,H.S. Kim,H.R. Kim,H.C. Chung,C.R. Kim,P. Hsyu,D. Averett,S. Worland,J. Kim +12 more
Journal ArticleDOI
Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization
Sangheun Lee,Jung Hyun Kang,Do Young Kim,Sang Hoon Ahn,Jun Yong Park,Beom Kyung Kim,Seung Up Kim,Kwang Hyub Han +7 more
TL;DR: Sorafenib is a potential rescue therapy in patients with TACE failure, however, the clinical benefits need to be further evaluated for patients with main (or lobar) PVI or those treated with reduced doses of sorafenIB.
Journal ArticleDOI
Efficacy and long-term follow up of combination therapy with interferon alpha and ribavirin for chronic hepatitis C in Korea.
Jie Hyun Kim,Kwang Hyub Han,Kwan Sik Lee,Young Nyun Park,Sang Hoon Ahn,Chae Yoon Chon,Young Myoung Moon +6 more
TL;DR: Combination therapy with interferon alpha (IFN-α) and ribavirin for 24 or 48 weeks according to HCV genotype has improved the overall sustained virological response (SVR) rates to approximately 40% as mentioned in this paper.
Journal ArticleDOI
Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy
Kwang Hyub Han,Jun Yong Park +1 more
TL;DR: See article in J. Gastroenterol.
Casein kinase II inhibitor enhances production of infectious genotype 1a hepatitis C virus (H77S).
TL;DR: In this article, casein kinase II (CKII) was identified as a crucial host factor in virus assembly by phosphorylating NS5A, and two approaches of CKII inhibition were investigated.